THE GLOBAL GENOMICS-BLOCKCHAIN ECOSYSTEM · PDF fileSHIVOM CORE TEAM Dr. Kayleen Schreiber Design Lead Kayleen communicates complex concepts to the general public through animation,

THE GLOBAL GENOMICS-BLOCKCHAIN

ECOSYSTEM

Copyright © 2018 Shivom | All rights reserved

SHIVOM VISIONWith SHIVOM everybody will be able to get their genome sequenced and stored, and our ecosystem will offer an open web-marketplace for other providers to add their apps and services, alongside genomic data analytics and personalized medicine.

Our solution will create shared value for individuals, not-for-profit organizations, governments, and for-profit entities alike.

We are building the largest genomic data-hub on the planet.


DISCLAIMERThis Pitch Deck may not be distributed in or transmitted to the United States or to U.S. persons. This presentation does not constitute an offer to sell or the solicitation of an offer to buy any OMX tokens in the United States or to U.S. persons. The OMX tokens have not been registered with the U.S. securities and exchange commission or under any state securities laws and may not be acquired, offered, sold or traded in the United States or by U.S. persons in the absence of registration under applicable U.S. federal and state laws or in reliance upon an applicable exemption.

GENOMICS

WHAT IS GENOMICS?

A highly interdisciplinary study of DNA that provides information about:

- Ancestry- Susceptible diseases- Potential drug treatments- Opportunities for precision medicine and new drug development- Many other things, some yet unknown

THE CHALLENGE

Unfortunately, genomic data is currently

siloed, inaccessible and doesn’t reach its full potential to improve

healthcare


0304

GENOMICSOTHER CHALLENGES

Critical data’s control in untrusted third party organizations

01

Huge market share and millions of revenue to large companies making money of donor’s data

Data being sold to for-profit institutions without donor’s knowledge or profit

02

Patients effectively paying twice for data and higher drug prices


EXPONENTIAL GROWTH IN MARKET

With falling genomics prices and huge growth in the genomics and large data analytics markets (a conservative CAGR of 11%) in the recent and projected years, there’s enormous potential for company growth

$ 100,000,000

$ 10,000,000

$ 1,000,000

$ 100,000

$ 10,000

$ 1,000

$ 100Sep 01 Sep 03 Sep 05 Sep 07 Sep 09 Sep 11 Sep 13 Sep 15 Sep 17 Sep 19

“


MARKET SIZE1. Global healthcare market: projected 8.7 trillion by 2020

2. Precision medicine market: projected 112.6 billion by 2025

3. “90% people in the United States will be sequenced within the next 20 years.” -Robin Thurston, CEO of Helix

India’s population is 1.3 billion individuals with the opportunity to sequence

nearly all of themCompany People Sequenced MarketValue

23andme 1M $1.1 B

AncestryDNA 4M $2.6 B

Helix N/A $100M (Raised)

Competition


BLOCKCHAIN TECH & ICOSInvestors should aim to buy tokens of projects that are likely to succeed and cause token’s value to rise (similar to VCs buying shares in start-ups).

Initial Coin Offering (ICO): opportunity for the general public to buy tokens that a company is planning to issue as part of the project they are building

Liquidity is achieved via crypto-exchanges, P2P and smart reserves (such as Bancor), which trade globally 24/7, with minimal fees and instant settlement

Token: unique cryptocurrency issued by company in a blockchain to provide utility, rights or economic value within a platform/ company

Tokens enable governance via smart contracts using the blockchain


THE SHIVOM ECOSYSTEMA decentralized blockchain where people can get their genome sequenced and stored, and an ecosystem where providers can add apps and services to drive personalized medicine, establishing a highly scalable and fully integrated healthcare vertical

Pharma

UserPhysician


05

SHIVOM SOLUTIONS

Decentralized blockchain where data being secured and owned by the donor completely

01

Whole genome tests at subsidized rates bringing mass adoption

Patients being incentivized directly for donating data to the research studies

0306

Complete control of the patient over the accessibility in a secure fashion

02

App marketplace and sharing economy on top of the blockchain for full genomic data integration

Single largest repository of genomic data for R&D, precision medicine, and DNA supercomputing

04


SHIVOM ECOSYSTEM A fully integrated, open, shareable, scalable community for all stakeholders

`

Data

Partner Organizations

Pharma

DeveloperCommunityPatients


PARTNERSHIP & BUSINESS MODELLeveraging partnerships and collaboration for maximum return

Very practical

TARGET CUSTOMERS

PARTNERSHIPS

GENERALTARGET PROFILE

COMPETITION

Any stakeholder who has a need for large genomic data sets, unique genomic datasets, and the ability to browse and filter genomic

data easily

Health Care Industry including R&D companiesPrivate and public research organizationsPharma companiesGovernmentNon-profit groups

We are partnership and collaboration focused and have already begun to amass partner organizations to join our mission goals.

We are actively working to collaborate with increasing numbers of partners across multiple industries

Sequencing companies: AncestryDNA, 23andMe, Illumina - only represent part of Shivom’s unique

product and service offeringOther companies that offer genomics data handling platforms or genomic analytic services don’t have the same vision to offer grand scale genomics marketplace and novel health economics platform; thus we see many of these companies as potential partners who can link up to our ecosystem and integrate their services within ours


PROOF OF CONCEPT PROJECT

23 & Me1M people sequenced

Market Value: USD $1.3B

Shivom’s first sequencing project

60X more people will be sequenced

Shivom23 & Me

Follow OnNetwork Effects and Partnerships

Will See Increased Growth


PROOF OF CONCEPT PRODUCT A platform for individuals and user groups to upload and analyze genomic

datasets

Individual/Patient Genome

Information

KeyGeneration

Public Key

Encrypt Decrypt

Private Key

Researcher

ho7ert83j\ajsd83jk0,s$ksd00kdg

Donor Dashboard: My Profile >> My Wallet >> My Data >> App Marketplace >> Privacy Settings

Pharma Dashboard: Company Profile >> Wallet Credits >> Data Sets >> Orders


PROOF OF CONCEPT PRODUCT Secure, Trusted and Functional Payment System Using an Established

Wallet


OMIX TOKENSThe OmiX token is a key component of the system that enables buying, trading, incentivizing and other upcoming services. The token is the fuel of an internal mechanism of the Shivom ecosystem, as well as part of the governance component of the system.

Benefits of omiX tokens- Acquiring premium services in the Shivom ecosystem

- Ability to acquire genome sequencing kits

- Ability to sponsor sequencing projects

- Acquiring access to health/fitness apps from 3rd party providers

- Ability to access the genome database

- Ability to pay data donor for data/participation in research studies

- Acquiring access for service providers to use the platform

Acquiring tokens- Token Sale

- Secondary Markets

- Rewards Collection


TOKEN DISTRIBUTION - 3 BILLION OMIX TOKENS

Token Sale:OmiX Token will be sold during the ICO process.Allocated: 990M OmiX utility tokens

Community:90M OmiX Token will be distributed to the community, for example in form of bounty programs to leverage network effects, growing the Shivom ecosystem, and for community initiatives to reward developers, entrepreneurs, and strategists to nurture a global healthcare network.

Founders:420M OmiX will be allocated for founders support for the development of the Shivom ecosystem and their continued long-term alignment with the project.

Advisors:300M OmiX will be allocated to early backers and the global network of advisors.

Incentivizing Growth Pool:600M OmiX of the total supply of tokens will be secured in a smart contract, allocated to the database, and introduced into circulation as rewards for data generation.

Company Reserve:600M OmiX will be kept by the Foundation as reserve fund for future data contribution, running the Foundation and associated non-profit R&D efforts. The Foundation maintains all authority to utilize a few or the majority of the reserve tokens held for major future externalinvestors.

Token Sale33%

Founders14%

Advisors10%

Growth Pool20%

Reserve20%

Community

Token Sale33%

3%


TOKEN SALE - USE OF PROCEEDSThe level of funding received dictates the distribution of funds, however, reserve structure allows us to reduce the volatility along the way towards achieving long-term objectives.

Platform development. Database building, UI, APIs, and metadata curating. A large part of this budget will be used to make the platform secure and scalable. From there we will be implementing new features along with the creation of the open marketplace.

Operations & Business Development. Day-to-day operations, team building (developers, geneticists, marketers and product managers). Forming the Foundation.

Non-profit R&D centre. Drug discovery platform combining elements of Big Data analytics, artificial intelligence, genomics, proteomics, lipidomics, and metabolomics.

Marketing & Forming Partnerships. Ongoing community building events and reaching the general public via traditional marketing channels and persona-based approaches. This includes also educational materials, roadshows, cooperating with other genomics-initiatives, organizing events and conferences, and KOL management.

Platform Development

20%

Operations11%

Legal5%

Sequencing PoC2%

Marketing21%

Data Storage

6%

Laboratories25%

R&D10%

Legal. Regulatory compliance for all markets where Shivom will operate.

Conducting initial PoC. First sequencing project in hospitals in rural India.

Data Storage. Forecasted to sustain platform for the first years.

Setting up labs. Setting up a global network of laboratories and counseling services.


SHIVOM LEADERSHIP TEAM

Dr. Axel SchumacherCo-Founder & CEOPh.D. Genetics, over 20 years of R&D leadership experience in genomics, epigenetics, biomarker discovery, Bio-IT, aging & longevity. Author of the ‘Blockchain & Healthcare Strategy Guide’, the standard compendium for the healthcare industry. Faculty Member, Blockchain Research Institute, Toronto.

Gourish SinglaCo-Founder & COOSerial Entrepreneur. Background in investment banking and wealth management. 4th Company in the Digital health space; Single-handedly established a unit and drove it $35 million revenue.

Sally Eaves Co-Founder & CMOExperienced Chief Technology Officer, one of the top 10 blockchain influencers, Practicing Professor of FinTech, Global Strategic Advisor, and member of the Forbes Technology Council of UK Govt.

Henry InesChief Innovation OfficerGlobal executive with extensive venture capital, cross-border advisory, corporate finance and entrepreneur experiences. As an investor, he focuses on FinTech / blockchain, frontier technologies and ventures based on his collective VC experiences to date. An advisor to multiple blockchain / ICOs and tech startups in Silicon Valley and beyond; and continues to maintain a pulse on latest technological innovations. Advisor and mentor to accelerators, incubators, entreprenuerial hubs & governments worldwide. Copyright © 2018 Shivom | All rights reserved

Akash GauravCTOBlockchain expert - started India’s first blockchain company, Auxesis Group (Top 100 blockchain companies) , Blockchain Lab, India, and is an advisor to the blockchain startup Cashaa ($15 million raised).

SHIVOM CORE TEAM

Dr. Natalie PankovaChief Scientific OfficerSerial entrepreneur, currently a director in 2 early stage health companies, with focus on ophthalmology and inflammatory diseases, 8+ years of University teaching experience and multiple roles in the non-profit sector.

Agam KansalVP MarketingCo-founded a funded startup in an IOT space, with a certificate course in Entrepreneurship from Stanford, has extensive experience in developing and implementing the communication strategies across organizations.


SHIVOM CORE TEAM

Stephane LaurentChinese Subcontinent HeadStarted his career in the field of conflict resolution, working for UN-backed projects in the Middle East, with strengths in international business analysis and development; currently manages a community of social entrepreneurs out of Shanghai.

Peng TingPublic Relations ManagerAssociate professor with demonstrated experience in higher education in Busan, South Korea. Background in International Relations and business anthropology. Consultant and translator for businesses and international education conferences. Radio show guest host. A truly passionate communicator.

Charles LeslieInvestment LeadCharles has a degree in Computer Science and a minor in Mathematics from the University of Alabama. He has been in technology for 20 years. A veteran from the internet boom era in the late 1990's. He has been in 4 startup companies. He has also worked in various technology for financial companies.

Pierre MaarekInvestment LeadCurrently head of the Equity Derivatives activities of Exane America. With 15 years in the industry working for the biggest players (JP Morgan in London, Natixis in Paris and now Exane in New York), he will bring his deep knowledge of the financial industry and his extensive network.


Dr. Kayleen SchreiberDesign LeadKayleen communicates complex concepts to the general public through animation, infographics, and writing. She displays the value of science and technology by highlighting wonder, process, challenges, and storytelling.

Azam ShaghaghiHead of Public RelationsAzam is an entrepreneur and blockchain consultant. She has the passion for innovation and disruptive technology to bring positive global change.

Ajit Singh KularHead of Digital MarketingWith over 8 years of experience in the Digital Marketing and SEO Industry, Ajit has handled various E-Commerce Sales and Product-based clients, including Fortune 500 companies. He is a resourceful and ambitious person who seeks challenges and growth by empowering organizations through SEO and Digital Marketing to drive results.

SHIVOM CORE TEAM


Dr. Rashad IbrahimMiddle East HeadBlockchain Enthusiast, Technology Imagineer and Technical Advisor of Smart Government transformation at Dubai Corporation for Ambulance Services - UAE. A medical Consultant and an IT Specialist with huge passion for Cryptography, Post Quantum Cryptography and Blockchain Technology.Worked for several international agencies in UN and, NGOs and Government Agencies.

SHIVOM INNOVATION COUNCIL


Dr. Amalio TelentiChief Data Scientist at Scripps Translational Science Institute and Chief Scientific Officer at Human Longevity Inc., a genomics company, Dr Telenti completed the largest study to date on whole genome deep sequencing in humans. His current research focuses on advancing the understanding on the 98% of the human genome that is dedicated to the regulation of the remaining 2% (protein coding genome) and to the analysis of the features of human genes essential for life.

Antanas GuogaLithuanian representative at the European Parliament, Antanas Guoga (TonyG) is an entrepreneur, venture capitalist investing in start-ups in the digital area, and philanthropist. Known for his efforts to promote a better climate for entrepreneurship and improving conditions for business opportunities. He is a well-known promoter and advocate of blockchain technology and crypto-currencies.

Dr. Jay SandersFather of Telemedicine, Dr. Jay Sanders is a graduate of Harvard Medical School, Dr. Sanders directs the U.S. telemedicine initiatives to the G-8 nations and is a founding member of the American Telemedicine Association. As a pioneer advocate and activist in the field of telemedicine, Dr. Sanders has trail-blazed a new frontier for physicians and the medical profession.

Taavi RõivasMr. Rõivas was the prime minister of the Republic of Estonia from 2014 to 2016. He was a member of the 11th, and is currently a member of the 12th term of Estonian Parliament, has chaired the European Union Affairs Committee, and been a member of the Social Affairs and Finance Committees of the Parliament. Mr. Rõivas is globally known as a digital influencer, promoting digitalisation of the governmental and business sectors, digital citizens rights, e-citizenship, e-voting and many other innovative and progressive initiatives.

Geoff HancockFounder of Advanced Cybersecurity Group, Geoff Hancock has spent 27 years in cybersecurity from Department of Defense and Intelligence community to other governments and global corporations. Over the last ten years, his work has been applying cybersecurity concepts and challenges to Blockchain, Artificial Intelligence, Genetics and Cybersecurity.

David OrbanFounder and Managing Partner of Network Society Ventures, David Orban’s entrepreneurial accomplishments span several companies founded and grown over more than twenty years. An early adopter of blockchain technologies since 2010, he was the first to own Ether during the Ethereum launch. He also led the adoption of Bitcoin and blockchain in start-ups and is an advisor and investor in numerous blockchain companies and funds.

Dr. William YasnoffKnown for his groundbreaking work leading to the creation of the Office of the National Coordinator for Health Information Technology in 2004 in the U.S.A. Dr. William Yasnoff accomplished consultant and national leader in health informatics, his focus is developing and implementing practical, real-world solutions to the most complex and difficult unsolved problems.

Dr. Irshaad EbrahimFellow of the Royal College of Psychiatrists, Dr Irshaad Ebrahim Neuropsychiatrist and Sleep Medicine Specialist, is actively involved in clinical research for new treatments for Insomnia, Depression and Anxiety Disorders. He is an early adopter of Blockchain Technology for Healthcare and has recently been appointed to advise several Crypto Funds on their Blockchain Healthcare Strategy

SHIVOM INNOVATION COUNCIL


Dr. Kamala K MaddaliDVM Ph.D., in Pharmacology from the University of Missouri-Columbia and a DVM Veterinary Medicine from Acharya N.G. Ranga Agricultural University in India. With over 12 years of experience in global P&L scientific and companion diagnostics (CDx) services covering personalized medicine strategies. She was Global Director Scientific Development -Biomarkers & Companion Diagnostics for Q2 Solutions. Currently Vice President at Cancer Genetics Inc, Rutherford, NJ.

GO TO MARKET STRATEGY

Collaborations: Working with medical centers, non-profit healthcare organizations, patient support groups and for-profit organizations to ensure a global and wide adoption of the platform

01Strong Global Marketing Campaigns03

Working directly with governments to get whole populations sequenced

04

Targeting quantify-self movements to spread the word that they can use their sequences from other providers. Shivom database can properly deliver value even when genomes from other genomics services such as 23andMe, AncestryDNA, Sure Genomics, Genos, NationalGeographic, GeneDx, Gencove, and others, are uploaded to the database.

05Incentives: To make these developments viable, we are implementing many incentives for people to use the platform. Eg, a user rewarded for participating in research studies, providing health information, or for recommending the platform to family and friends.

Bounties: Rewards (including tokens, cryptocurrency, free health apps or discounts) can also be earned for the creation of original social media content, social promotions, sharing research campaigns, or using apps, encouraging word of mouth marketing.

02


MILESTONES COMING UP

Proof of ConceptSuccessful PoC will

carried out Q1 of 2018

Token SaleOmiX tokens on sale

April 2018

Product LaunchBeta version launched to

partners and public Q1/Q2 of 2018 .


ROADMAP


SHIVOM PARTNERS


CARJAY INVESTMENTS PTY LTD

Technique Capital

the merchant

group


CONTACT USWe are building the world’s largest blockchain powered digital genome repository.

Website: www.shivom.ioEmail: [email protected]

http://shivom.slack.com

http://facebook.com/projectshivom

http://discord.me/shivom

http://medium.com/@projectshivom

http://instagram.com/projectshivom

https://t.me/projshivom

http://linkedin.com/company/18302733/

http://twitter.com/projectshivom

This document is the property of Shivom and Omix Ventures Pvt Ltd, any unauthorized reproduction may result in legal action.Copyright © 2018 Shivom | All rights reserved

Documents

THE GLOBAL GENOMICS-BLOCKCHAIN ECOSYSTEM · PDF fileSHIVOM CORE TEAM Dr. Kayleen Schreiber Design Lead Kayleen communicates complex concepts to the general public through animation,